EGFR and adrenal cortex carcinoma: Recently, we identified a mucoepidermoid carcinoma and an ACC with a TKI-sensitising EGFR exon 19 deletion mutation by screening EGFR exons 19 and 21 for the two most common hotspot mutations by an allele-specific PCR test (Dahse and Kosmehl, 2008).